{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:43:46Z","timestamp":1790613826474,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clinre.2021.101626","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T18:03:19Z","timestamp":1614103399000},"page":"101626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["HCV virology and diagnosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Steven","family":"Roger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Ducancelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Le Guillou-Guillemette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Gaudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Lunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2021.101626_bib0005","series-title":"Global hepatitis report, 2017","author":"World Health Organization, Global Hepatitis Programme","year":"2017"},{"key":"10.1016\/j.clinre.2021.101626_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2021.101626_bib0015","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/hep.31182","article-title":"Hepatitis C vaccine: 10 good reasons for continuing","volume":"71","author":"Roingeard","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101626_bib0020","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/liv.14541","article-title":"Mixing particles from various HCV genotypes increases the HBV\u2010HCV vaccine ability to elicit broadly cross\u2010neutralizing antibodies","volume":"40","author":"Beaumont","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2021.101626_bib0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM197504102921502","article-title":"Transfusion-associated hepatitis not due to viral hepatitis type a or B","volume":"292","author":"Feinstone","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2021.101626_bib0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.277.5325.570","article-title":"Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA","volume":"277","author":"Kolykhalov","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.clinre.2021.101626_bib0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.clinre.2021.101626_bib0040","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1101794108","article-title":"Characterization of a canine homolog of hepatitis C virus","volume":"108","author":"Kapoor","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinre.2021.101626_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003438","article-title":"Evidence for Novel Hepaciviruses in Rodents","volume":"9","author":"Drexler","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinre.2021.101626_bib0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1006\/bbrc.1995.2526","article-title":"A novel sequence found at the 3\u2032-Terminus of hepatitis C virus genome","volume":"215","author":"Tanaka","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinre.2021.101626_bib0055","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/jvi.66.3.1476-1483.1992","article-title":"Internal ribosome entry site within hepatitis C virus RNA","volume":"66","author":"Tsukiyama-Kohara","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00274","article-title":"Protective immunity against hepatitis C: many shades of gray","volume":"5","author":"Abdel-Hakeem","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinre.2021.101626_bib0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-1119(92)90216-C","article-title":"Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase","volume":"122","author":"Steinhauer","year":"1992","journal-title":"Gene"},{"key":"10.1016\/j.clinre.2021.101626_bib0070","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1073\/pnas.88.8.3392","article-title":"Nucleotide sequence and mutation rate of the H strain of hepatitis C virus","volume":"88","author":"Ogata","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinre.2021.101626_bib0075","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0042-6822(92)90933-G","article-title":"Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability","volume":"190","author":"Okamoto","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.clinre.2021.101626_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2893.1999.00010.x","article-title":"Evolution of the hypervariable region of hepatitis C virus","volume":"6","author":"Smith","year":"1999","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2021.101626_bib0085","doi-asserted-by":"crossref","first-page":"38838","DOI":"10.1074\/jbc.M204657200","article-title":"Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis","volume":"277","author":"Labont\u00e9","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2021.101626_bib0090","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1128\/JCM.41.8.3615-3622.2003","article-title":"Significance\u202fof pretreatment analysis of hepatitis C virus genotype 1b hypervariable region 1 sequences to predict antiviral outcome","volume":"41","author":"Gaudy","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2021.101626_bib0095","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1093\/emboj\/17.13.3521","article-title":"Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1can induce antibodies cross-reacting with a large number of viral variants","volume":"17","author":"Puntoriero","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.clinre.2021.101626_bib0100","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1128\/JVI.73.4.2938-2946.1999","article-title":"Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy","volume":"73","author":"Ray","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0105","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded\u202fclassification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101626_bib0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1099\/jgv.0.000672","article-title":"ICTV Virus Taxonomy Profile: Flaviviridae","volume":"98","author":"Simmonds","year":"2017","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00945022","article-title":"The quasispecies of hepatitis\u202fC virus and the host immune response","volume":"19","author":"Farci","year":"1997","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.clinre.2021.101626_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010023","article-title":"Hepatitis C Virus: Viral Quasispecies and Genotypes","volume":"19","author":"Tsukiyama-Kohara","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinre.2021.101626_bib0130","doi-asserted-by":"crossref","first-page":"20509","DOI":"10.1073\/pnas.1105797108","article-title":"Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance","volume":"108","author":"Powdrill","year":"2011","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"10.1016\/j.clinre.2021.101626_bib0135","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1128\/jvi.67.7.3923-3930.1993","article-title":"Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp7O) of hepatitis C virus","volume":"67","author":"Kato","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000150366","article-title":"Immunological aspects of HCV infection","volume":"37","author":"Cerny","year":"1994","journal-title":"Intervirology"},{"key":"10.1016\/j.clinre.2021.101626_bib0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00705-004-0470-0","article-title":"Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection","volume":"150","author":"Higashi","year":"2005","journal-title":"Arch Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0155","unstructured":"de Oliveira T., Salemi M., Pybus O., Almeida S., Rambaut A. BioAfrica.net. BioAfrica - Oxf HCV Subtyping Tool. http:\/\/www.bioafrica.net\/subtypetool\/html\/subtypeprocesshcv.html (accessed November 20, 2020)."},{"key":"10.1016\/j.clinre.2021.101626_bib0160","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1128\/JCM.44.2.614-616.2006","article-title":"Unique NS5b hepatitis C virus gene sequence consensus database is essential for standardization of genotype determinations in multicenter epidemiological studies","volume":"44","author":"Laperche","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2021.101626_bib0165","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3748\/wjg.v13.i17.2416","article-title":"Genetic diversity of the hepatitis C virus: impact and issues in the antiviral therapy","volume":"13","author":"Le Guillou-Guillemette","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2021.101626_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution\u202fand prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101626_bib0175","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/JCM.02831-14","article-title":"Hepatitis C virus genotype 7, a new genotype originating from Central Africa","volume":"53","author":"Murphy","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2021.101626_bib0185","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.3390\/v7092857","article-title":"Genetic diversity and selective pressure in hepatitis C virus genotypes 1\u20136: significance for direct-acting antiviral treatment and drug resistance","volume":"7","author":"Cuypers","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.clinre.2021.101626_bib0195","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1126\/science.1058321","article-title":"The epidemic behavior of the hepatitis C virus","volume":"292","author":"Pybus","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.clinre.2021.101626_bib0200","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1073\/pnas.96.23.13034","article-title":"Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus","volume":"96","author":"Bressanelli","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinre.2021.101626_bib0205","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1159\/000351621","article-title":"Molecular epidemiology and genetic history of hepatitis C virus subtype 3a infection in Thailand","volume":"56","author":"Akkarathamrongsin","year":"2013","journal-title":"Intervirology"},{"key":"10.1016\/j.clinre.2021.101626_bib0210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1099\/0022-1317-82-4-693","article-title":"2000 Fleming Lecture. The origin and evolution of hepatitis viruses in humans","volume":"82","author":"Simmonds","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2014.07.006","article-title":"Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa","volume":"464\u2013465","author":"Iles","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.clinre.2021.101626_bib0220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virol.2014.07.026","article-title":"The genetic diversity and evolutionary history of hepatitis C virus in Vietnam","volume":"468\u2013470","author":"Li","year":"2014","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.clinre.2021.101626_bib0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0168-8278(94)80149-5","article-title":"Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy","volume":"21","author":"Orito","year":"1994","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.clinre.2021.101626_bib0230","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/172.4.934","article-title":"Hepatitis C Virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics","volume":"172","author":"Kohara","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinre.2021.101626_bib0235","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL\u202fRecommendations on Treatment of Hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0240","first-page":"5","article-title":"Mutations in the nonstructural protein 5a gene and response to interferon in patients with chronic hepatitis C virus 1b infection","author":"Nobuyuki","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2021.101626_bib0245","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/339051","article-title":"Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity","volume":"185","author":"Castelain","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinre.2021.101626_bib0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199601113340203","article-title":"Mutations in the nonstructural protein 5a gene and response to interferon in patients with chronic hepatitis C virus 1b infection","volume":"334","author":"Enomoto","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2021.101626_bib0255","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1365-2893.2002.00379.x","article-title":"Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?","volume":"9","author":"Squadrito","year":"2002","journal-title":"J Viral Hepat"},{"issue":"4","key":"10.1016\/j.clinre.2021.101626_bib0260","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<353::AID-JMV6>3.0.CO;2-C","article-title":"Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus","volume":"58","author":"Chung","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0265","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1440-1746.2006.04566.x","article-title":"Mutations in ISDR of NS5A gene influence interferon efficacy in Chinese patients with chronic hepatitis C virus genotype 1b infection","volume":"22","author":"Shen","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0270","first-page":"5","article-title":"Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates","author":"Inchauspe","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt6","key":"10.1016\/j.clinre.2021.101626_bib0275","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1099\/0022-1317-79-6-1373","article-title":"Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity","volume":"79","author":"Duverlie","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0280","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1099\/vir.0.80526-0","article-title":"Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C","volume":"86","author":"Puig-Basagoiti","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0285","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.patbio.2004.07.011","article-title":"Analyse des mutations des domaines ISDR et V3 de la prot\u00e9ine NS5A du virus de l\u2019h\u00e9patite C avant le traitement par l\u2019interf\u00e9ron avec ou sans ribavirine","volume":"52","author":"Veillon","year":"2004","journal-title":"Pathol Biol"},{"key":"10.1016\/j.clinre.2021.101626_bib0290","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen","volume":"20","author":"Lonardo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2021.101626_bib0295","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0300","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2021.101626_bib0305","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gut.2010.236158","article-title":"Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2\/3","volume":"61","author":"Thompson","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2021.101626_bib0310","doi-asserted-by":"crossref","first-page":"27025","DOI":"10.1038\/srep27025","article-title":"Impact of HCV core gene quasispecies on hepatocellular carcinoma risk among HALT-C trial patients","volume":"6","author":"El-Shamy","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinre.2021.101626_bib0315","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jvh.13303","article-title":"The role of hepatitis C virus genotypes and core mutations in hepatocellular carcinoma in Cameroon","volume":"27","author":"Amougou-Atsama","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2021.101626_bib0320","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1053\/j.gastro.2012.02.016","article-title":"Animal models for the study of hepatitis C virus infection and related liver disease","volume":"142","author":"Bukh","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2021.101626_bib0325","first-page":"49","article-title":"Animal models for hepatitis C","volume":"vol. 369","author":"Billerbeck","year":"2013"},{"key":"10.1016\/j.clinre.2021.101626_bib0330","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2021.101626_bib0335","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon Alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C","volume":"339","author":"McHutchison","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2021.101626_bib0340","first-page":"167","article-title":"Hepatitis C virus\u202fRNA replication","volume":"vol. 369","author":"Lohmann","year":"2013"},{"key":"10.1016\/j.clinre.2021.101626_bib0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.clinre.2021.101626_bib0350","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.clinre.2021.101626_bib0355","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/hep.25738","article-title":"Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection","volume":"56","author":"Lagaye","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2021.101626_bib0360","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00198849","article-title":"Association of hepatitis C virus in human sera with beta-lipoprotein","volume":"181","author":"Thomssen","year":"1992","journal-title":"Med microbiol Immunol"},{"key":"10.1016\/j.clinre.2021.101626_bib0365","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinre.2021.101626_bib0370","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/v6031149","article-title":"Incorporation of Hepatitis C Virus E1 and E2 Glycoproteins: The Keystones on a Peculiar Virion","volume":"6","author":"Vieyres","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.clinre.2021.101626_bib0375","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-Density hepatitis C virus RNA-Containing particles","volume":"76","author":"Andr\u00e9","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0380","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1128\/JVI.01091-07","article-title":"Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture","volume":"81","author":"Chang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0385","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2021.101626_bib0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000762","article-title":"The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule","volume":"6","author":"Krey","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinre.2021.101626_bib0395","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.clinre.2021.101626_bib0400","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2021.101626_bib0405","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1128\/JVI.02642-06","article-title":"Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus","volume":"81","author":"Lavillette","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0410","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.26733","article-title":"Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry: Hepatology","volume":"59","author":"Douam","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101626_bib0415","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and cell biology of the hepatitis C virus life\u202fcycle \u2013 An update","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0420","first-page":"113","article-title":"Hepatitis C virus proteins: from structure to function","volume":"vol. 369","author":"Moradpour","year":"2013"},{"key":"10.1016\/j.clinre.2021.101626_bib0430","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.coviro.2012.09.013","article-title":"Hepatitis C virus\u2014host interactions, replication, and viral assembly","volume":"2","author":"Shulla","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0435","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/ncb1631","article-title":"The lipid droplet is an important organelle for hepatitis C virus production","volume":"9","author":"Miyanari","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.clinre.2021.101626_bib0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003355","article-title":"Hepatitis C virus p7 is critical for capsid assembly and envelopment","volume":"9","author":"Gentzsch","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinre.2021.101626_bib0450","doi-asserted-by":"crossref","first-page":"18904","DOI":"10.1074\/jbc.M113.538256","article-title":"The Association of Hepatitis C Virus Glycoproteins with Apolipoproteins E and B Early in Assembly Is Conserved in Lipoviral Particles","volume":"289","author":"Boyer","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2021.101626_bib0455","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/gutjnl-2016-311726","article-title":"Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture","volume":"66","author":"Piver","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2021.101626_bib0460","series-title":"Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests \u00c9valuation et am\u00e9lioration du diagnostic \ufb01able de cirrhose par les tests sanguins","first-page":"11","author":"Cal\u00e8s","year":"2020"},{"key":"10.1016\/j.clinre.2021.101626_bib0465","first-page":"11","article-title":"Improved fibrosis staging by elastometry and blood test in chronic hepatitis C","author":"Cale","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2021.101626_bib0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0475","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2468-1253(17)30045-6","article-title":"Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study","volume":"2","author":"Razavi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0480","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bpg.2008.11.004","article-title":"Diagnosis and management of chronic viral hepatitis: antigens, antibodies and viral genomes","volume":"22","author":"Chevaliez","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2021.101626_bib0485","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/cis368","article-title":"Laboratory diagnostics for hepatitis C virus infection","volume":"55","author":"Kamili","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinre.2021.101626_bib0490","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jcv.2012.07.016","article-title":"Performance of an antigen\u2013antibody combined assay for hepatitis C virus testing without venipuncture","volume":"55","author":"Larrat","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0495","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3748\/wjg.v20.i11.2948","article-title":"Current testing strategies for hepatitis C virus infection in blood donors and the way forward","volume":"20","author":"Marwaha","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2021.101626_bib0500","first-page":"718","article-title":"[Virological tools for the diagnosis and follow up of hepatitis C: use and role of new tests]","volume":"27","author":"Lunel-Fabiani","year":"2003","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2021.101626_bib0505","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1246-7820(03)00028-4","article-title":"Antig\u00e8ne et charge virale","volume":"10","author":"Lunel","year":"2003","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.clinre.2021.101626_bib0510","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/JCM.43.4.1722-1726.2005","article-title":"Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup","volume":"43","author":"Gaudy","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2021.101626_bib0515","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1128\/JCM.41.7.3212-3220.2003","article-title":"Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy","volume":"41","author":"Veillon","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2021.101626_bib0520","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.patbio.2004.07.036","volume":"52","author":"Pivert","year":"2004","journal-title":"Pathol Biol"},{"key":"10.1016\/j.clinre.2021.101626_bib0525","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2014.05.014","article-title":"Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C","volume":"61","author":"Chevaliez","year":"2014","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0530","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jviromet.2017.03.002","article-title":"HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients","volume":"245","author":"Rockstroh","year":"2017","journal-title":"J Virol Methods"},{"key":"10.1016\/j.clinre.2021.101626_bib0535","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2017.05.007","article-title":"Hepatitis C virus core antigen: a simplified treatment monitoring tool, including for post-treatment relapse","volume":"92","author":"Lamoury","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0540","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3851\/IMP3042","article-title":"Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen","volume":"23","author":"Chevaliez","year":"2016","journal-title":"Antivir Ther (Lond)"},{"key":"10.1016\/j.clinre.2021.101626_bib0545","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jhep.2018.05.017","article-title":"New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings","volume":"69","author":"Chevaliez","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2021.101626_bib0550","first-page":"3","article-title":"Detection and quantification of serum or plasma HCV RNA: mini review of commercially available assays","volume":"vol. 510","author":"Guillou-Guillemette","year":"2009"},{"key":"10.1016\/j.clinre.2021.101626_bib0555","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/j.gastro.2012.02.027","article-title":"New Virologic Tools for Management of Chronic Hepatitis B and C","volume":"142","author":"Chevaliez","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2021.101626_bib0560","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcv.2017.01.006","article-title":"Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection","volume":"88","author":"Gupta","year":"2017","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clinre.2021.101626_bib0565","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/JCM.02460-16","article-title":"Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay","volume":"55","author":"McHugh","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinre.2021.101626_bib0570","article-title":"Dried blood spot for hepatitis C virus serology and molecular testing","author":"Tuaillon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101626_bib0575","doi-asserted-by":"crossref","first-page":"459.e1","DOI":"10.1016\/j.cmi.2016.01.009","article-title":"Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care","volume":"22","author":"Chevaliez","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinre.2021.101626_bib0585","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/ijmr.IJMR_1850_16","article-title":"Genotyping &\u202fdiagnostic methods for hepatitis C virus: A need of low-resource countries","volume":"147","author":"Kumar","year":"2018","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.clinre.2021.101626_bib0590","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural history of hepatitis C","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.clinre.2021.101626_bib0595","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus: HEPATITIS C VIRUS GUIDANCE PANEL","volume":"62","author":"AASLD\/IDSA HCV Guidance Panel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2021.101626_bib0605","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1128\/jcm.34.9.2259-2266.1996","article-title":"Second-generation line probe assay for hepatitis C virus genotyping","volume":"34","author":"Stuyver","year":"1996","journal-title":"J Clin Microbiol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012100005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221074012100005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T11:18:07Z","timestamp":1755083887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221074012100005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":113,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S221074012100005X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101626","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HCV virology and diagnosis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2021.101626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"101626"}}